Michael Leek
Chief Executive Officer at TCB Newco Ltd.
Michael Leek active positions
| Companies | Position | Start | End |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Founder | - | - |
Career history of Michael Leek
Former positions of Michael Leek
| Companies | Position | Start | End |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 01/01/2013 | 01/06/2021 |
| Chairman | 01/01/2013 | 14/02/2023 | |
| Chief Tech/Sci/R&D Officer | 14/02/2023 | 01/06/2023 | |
| Founder | 01/01/2013 | 01/06/2023 | |
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Chief Operating Officer | 01/01/2000 | 03/02/2006 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | 01/01/2014 | - |
| Founder | 01/01/2014 | - |
Training of Michael Leek
| University of Leeds | Doctorate Degree |
Statistics
International
| United Kingdom | 6 |
Operational
| Chief Executive Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 3 |
|---|---|
Intercytex Ltd.
Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Stock Market
- Insiders
- Michael Leek
- Experience
